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Opioid Use, Abuse and Treatment


Opiates are a frequently prescribed medication for the treatment of
pain, particularly in the post-operative setting (1).



Higher rates of opioid analgesic prescription are associated with higher
rates of opoid abuse and addiction (2).



Opioid abuse in Vermont is an epidemic; 6% of 12-17 year olds, 12% of
18-25 year olds, and 3% of people 26 years or older report non-medical
use of prescription pain killers as of 2012 (3).



Medically assisted treatment (MAT) of Opioid Addiction is associated
with increased quality of life (4), and its use is becoming more widely
accepted among providers in ambulatory treatment centers (5).



Vermont has adopted a “Hub and Spoke” model of substance abuse
MAT in which the level of intervention and supervision is titrated to the
risk profile of the patient (6).

Economic Burden of Opioid Abuse


As of 2007, Birnbaum et al. (7) estimated that the annual societal
costs of opiate prescription abuse in the United States was $55.7
billion.



These costs included:


Lost productivity in the workforce ($25.6 billion)



Healthcare expenses ($25 billion)



Expenses related to the criminal justice system ($5.1 billion)

Community Perspectives




Suboxone patients, on how they first started using opiates:


“My girlfriend and I just thought, what the hell, let’s try it. It was great, and we started using
more and more often. Before long though, the pills were getting too expensive and someone
suggested I try heroine instead. It works, and it’s cheap, but it leaves me feeling like I’m
disgusting. I don’t think people know how much I’m using.”



“I started using in College. I tried to quit a few times, but last time I relapsed they caught me
driving and I lost my license. I’ve been having to ask people for rides down to Boston and
back once a month to go to a Suboxone clinic down there.”

Local Physician




“The numbers are just too high (looking at rates of adolescent opiate use in VT). Everyone has
been affects in some way, either they themselves, or someone in their family. Even if they
don’t know they know someone. That’s why we’re trying to expand the amount of Suboxone
treatment that we do here at CHCRR”

Member of Brandon Cares community group


“It’s such an incredibly huge problem, not just in Vermont, but everywhere. The cousin of one
of the women here in town lost both of her sons on the same day to opiate overdose. Really
sad. That’s the really scary part about the drugs on the street, no one knows what they’re
laced with or what’s in them or what.”

Intervention and Methodology


Review of currently available resources and information regarding
opiate abuse and its treatment in Vermont



Creation of a single, easily digestible pamphlet for providing
information to opiate abusers that are considering treatment for
their addictions



This pamphlet includes:


An overview of opiate abuse in Vermont



Introduction to the “Hub and Spoke” MAT system in Vermont



Consolidated list of treatments centers specializing in substance abuse
and licensed alcohol and drug abuse counselors in the area

Response


The response from care providers at the Brandon Medical Center
was positive. Physicians expressed enthusiasm at having a
consolidated informational handout to either leave in the waiting
room or to give to patients directly.

Effectiveness and Limitations




The purpose of this project was to provide a safe, low threshold source of
information to people considering treatment for opiate addiction. Since the
pamphlet’s use is designed to be, at least in part, anonymous, it is difficult to
directly assess its effectiveness. That said there are two ways to assess whether
the pamphlet is being used:


Checks on how quickly pamphlets are being taken from the waiting room



Asking new enrollees into the suboxone program how they first became aware of the
“hub and spoke” system

This pamphlet represents one more in a long list of potential routes toward
treatment. Whether it is responsible for simply planting the seed in a person’s
mind or for being the final straw that gets that person to call in for help is not
important.




“If this ends up helping even just one person, it will be time well spent.”

Limitations: This pamphlet is primarily targeted towards the patient population
seen at the Brandon Medical Center, and therefore only includes specific
informational listings for Addison and Rutland County

Future Interventions


In the future, it would be useful to gather information about how
those patients that do actually become enrolled in MAT programs
first learn about the programs, what it was that made them want to
become involved, and what was difficult about the steps in
becoming enrolled.



With this information, providers may be better equipped to lower the
threshold for potential enrollees to reach out for help.



Susan Roy of the Brandon Cares group and Amy Kitteridge, a LADC
at the Brandon Medical Center, are both useful contacts.
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